Stockreport

Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004) [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF - Pfizer Ignite is responsible for the clinical execution of the trial - - Initial topline results expected in mid-2024 – - Company will hold a conference call toda [Read more]